Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
48 participants
OBSERVATIONAL
2021-01-01
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Could the images of enhanced 3D-WATSc sequence show the healthy side hip joint vessels in children?
* Could the images of enhanced 3D-WATSc sequence show the vascular disease of the suffering side hip joint in children?
Participants with unilateral hip disease will undergo the magnetic resonance examination including enhanced 3D-WATSc sequence. The pelvic plain film and magnetic resonance images will be collected and analysed.
Researchers will compare the images of of the normal side with the images of the abnormal side to see if the enhanced 3D-WATSc sequence images could show the vascular disease of the suffering side hip joint in children?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Geometry of the Immature Human Femur Before the Age of 3 Years From Data Measured on CT Scan
NCT05620394
Ultrasound and MRI Measurement of Quadriceps Femoris Muscle in Critically Ill Children
NCT05108441
Magnetic Resonance Imaging Autopsy Study
NCT01417962
MRI-Volumetry in the Evaluation of Shunt Treatment for Hydrocephalus
NCT04599153
Retrospective Review of CT and MR in Pediatric Patients With Cholestasis
NCT01252043
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal hip joint
The normal side of patients with hip joint disease
Magnetic resonance examination
the two groups are underwent magnetic resonance examination including enhanced 3D-WATSc sequence
Abnormal hip joint
The abnormal side of patients with hip joint disease
Magnetic resonance examination
the two groups are underwent magnetic resonance examination including enhanced 3D-WATSc sequence
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic resonance examination
the two groups are underwent magnetic resonance examination including enhanced 3D-WATSc sequence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Months
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yuxi Su
Orthopaedic Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuxi Su, M.D.
Role: STUDY_CHAIR
Children's Hospital of Chongqing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CQMU-2023-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.